Posted on January 17, 2020 in Blog
Jeff Patton, MD, Tennessee Oncology, CEO, OneOncology, President of Physician Services Happy New Year All. It’s January 2020 and an ideal time to review highlights of the year past and hopes for the year ahead. But first, thanks for your interest in Patton family news, Mary and I are always proud to share updates on […]
Read MorePosted on January 16, 2020 in News
January 13, 2020; Nashville, TN – OneOncology, the national network of independent community oncologists, announced today its new partnership with Eastern Connecticut Hematology and Oncology (ECHO) as the company expands its footprint across New England. ECHO, a privately-owned, independent practice, has served north and southeast Connecticut for more than 30 years. ECHO’s physicians, advanced practice providers, nurses and […]
Read MorePosted on December 13, 2019 in News
Read original article HERE. Stephen M Schleicher, MD, MBA, medical oncologist at Tennessee Oncology and medical director of value-based care at OneOncology, and colleagues recently published a viewpoint article in JAMA Oncology on how the Oncology Care Model (OCM) could better foster the use of appropriate cancer therapies. Journal of Clinical Pathways spoke with Dr […]
Read MorePosted on November 13, 2019 in News
Seeking the Win/Win/Win for Patients, Practices, Payers Read the original Nashville Medical News article HERE At this point in the move from fee-for-service to value-based reimbursement, everyone in healthcare is familiar with the triple aim of improving the patient care experience, improving the health of populations and reducing the per capita cost of care delivery. […]
Read MorePosted on November 5, 2019 in News
Read original article HERE. Journal of American Medical Association Publishes Study Conducted at Tennessee Oncology OneOncology leaders — Aaron Lyss, MBA and Stephen Schleicher, MD, MBA — and leaders at Tuple Health, published an article in the Journal of American Medical Association (JAMA) Oncology examining the implications of the newly approved standard-of-care immunotherapies within the […]
Read More